Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmune polyglandular syndromes].

T O Lankisch1, E Jaeckel, C P Strassburg

  • 1Abteilung für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover.

Der Internist
|June 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The challenge of replicating putative genetic risk factors in a population-based database.

Journal of gastroenterology and hepatology·2024
Same author

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases.

ESMO open·2023
Same author

Percutaneous Transsplenic Balloon-Assisted Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Portal Vein Obliteration for Portal Vein Recanalization: Feasibility, Safety and Effectiveness.

Cardiovascular and interventional radiology·2022
Same author

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients.

Journal of molecular medicine (Berlin, Germany)·2020
Same author

Dye chromoendoscopy leads to a higher adenoma detection in the duodenum and stomach in patients with familial adenomatous polyposis.

Endoscopy international open·2020
Same author

Parameters predicting COVID-19-induced myocardial injury and mortality.

Life sciences·2020
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Autoimmune polyglandular syndromes (APS) are rare endocrine disorders. Autoimmune Polyglandular Syndrome Type I (APECED) and Type 2 (APS-2) differ in genetics, symptoms, and affected populations, requiring distinct management strategies.

Area of Science:

  • Endocrinology
  • Immunology
  • Genetics

Context:

  • Autoimmune polyglandular syndromes (APS) are rare autoimmune endocrinopathies.
  • APECED and APS-2 are distinct subtypes with differing genetic associations and clinical presentations.
  • APECED is linked to AIRE gene mutations, primarily affecting juveniles with specific ethnic backgrounds.

Purpose:

  • To differentiate between Autoimmune Polyglandular Syndrome Type I (APECED) and Autoimmune Polyglandular Syndrome Type II (APS-2).
  • To outline the diagnostic criteria, genetic associations, and epidemiological characteristics of APECED and APS-2.
  • To discuss current therapeutic approaches, including hormone replacement and potential immunosuppressive therapies for APECED.

Summary:

  • APECED, associated with AIRE gene mutations, presents with adrenal insufficiency, hypoparathyroidism, and candidiasis, often in juvenile patients from specific populations.

Related Experiment Videos

  • APS-2, not AIRE-associated, involves autoimmune thyroid disease, adrenal insufficiency, and/or type 1 diabetes mellitus, primarily affecting adult women across diverse ethnic groups.
  • Diagnosis for APECED requires two of the three main symptoms, while APS-2 is more common and lacks specific ethnic predilection.

    • Impact:

    • Provides a clear distinction between APECED and APS-2 for accurate diagnosis and patient stratification.
    • Highlights the genetic basis of APECED (AIRE gene) and its implications for understanding autoimmune diseases.
    • Informs therapeutic strategies, emphasizing hormone replacement and exploring novel treatments like immunosuppression for APECED.